Natixis Advisors LLC Buys 1,552 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Natixis Advisors LLC raised its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,392 shares of the biotechnology company’s stock after acquiring an additional 1,552 shares during the period. Natixis Advisors LLC’s holdings in Axon Enterprise were worth $12,145,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Mizuho Securities USA LLC grew its stake in shares of Axon Enterprise by 1,077.9% in the 3rd quarter. Mizuho Securities USA LLC now owns 64,418 shares of the biotechnology company’s stock valued at $25,741,000 after purchasing an additional 58,949 shares during the period. Empirical Finance LLC raised its stake in Axon Enterprise by 9.8% during the third quarter. Empirical Finance LLC now owns 1,038 shares of the biotechnology company’s stock worth $415,000 after acquiring an additional 93 shares in the last quarter. Signature Estate & Investment Advisors LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth about $210,000. CIBC Asset Management Inc lifted its holdings in Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Finally, OneDigital Investment Advisors LLC boosted its position in Axon Enterprise by 35.8% in the third quarter. OneDigital Investment Advisors LLC now owns 2,053 shares of the biotechnology company’s stock valued at $820,000 after buying an additional 541 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AXON. Barclays raised their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Needham & Company LLC boosted their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $609.82 on Thursday. The company has a fifty day moving average price of $453.48 and a 200 day moving average price of $363.68. Axon Enterprise, Inc. has a 1-year low of $224.28 and a 1-year high of $624.84. The firm has a market cap of $46.50 billion, a PE ratio of 157.58, a PEG ratio of 15.05 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 70,000 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $362.21, for a total value of $25,354,700.00. Following the sale, the chief executive officer now directly owns 2,945,366 shares of the company’s stock, valued at approximately $1,066,841,018.86. This represents a 2.32 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. This trade represents a 10.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 410,556 shares of company stock worth $161,192,754. 5.70% of the stock is owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.